400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2026-01-28
前庭功能障碍治疗药物开发商
医药研发/制造
化学&生物药
Sphera Global Healthcare Fund;
Sphera Global Healthcare Fund;
赛诺菲;
赛诺菲;
Sofinnova Partners;
鱼鹰资管;
Redmile Group;
Artal;
2026-01-28
细胞疗法综合开发与制造商
医药研发/制造
化学&生物药
Eclipse Ventures;
Eclipse Ventures;
BlackRock;
BlackRock;
Willett Advisors LLC;
DFJ Growth;
Gates Frontier;
新加坡经济发展局投资;
Intuitive Ventures;
Duquesne Family Office;
Baillie Gifford;
T. Rowe Price;
2026-01-28
眼科治疗药物研发商
医药研发/制造
化学&生物药
Janus Henderson Investors;
Janus Henderson Investors;
高瓴资本;
高瓴资本;
British Business Bank;
EQT Partners;
Sofinnova Partners;
F-Prime Capital;
Eight Roads Ventures;
启明创投;
AdBio partners;
Wille Finance;
2026-01-27
免疫疗法研发商
医药研发/制造
化学&生物药
SV Health Investors;
SV Health Investors;
Polaris Partners;
Polaris Partners;
辉瑞;
Johnson & Johnson Innovation;
Eli Lilly;
Delos Capital;
Avego Bioscience Capital;
Alexandria Venture Investments;
Affinity Asset Advisors;
Balyasny Asset;
Janus Henderson Investors;
2026-01-27
小分子药物研发商
医药研发/制造
化学&生物药
ATHOS Service;
Global Health Investment Corporation;
2026-01-26
实体瘤TCR-T细胞治疗药物研发商
医药研发/制造
化学&生物药
格林美;
格林美;
德联资本;
德联资本;
同高投资;
苏创投;
元禾控股;
杏泽资本;
2026-01-26
免疫细胞靶向生物制剂及抗体偶联药物研发商
医药研发/制造
化学&生物药
骊宸投资;
骊宸投资;
上实生物医药创新转化私募投资基金;
上实生物医药创新转化私募投资基金;
险峰;
Taihill Venture;
沂景资本;